Works matching IS 02704137 AND DT 2019 AND VI 79 AND IP 3

Results: 11

Tumor‐infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?

Published in:

Prostate, 2019, v. 79, n. 3, p. 320, doi. 10.1002/pros.23738

By:

Krueger, Timothy E.;
Thorek, Daniel L. J.;
Meeker, Alan K.;
Isaacs, John T.;
Brennen, W. Nathaniel

Publication type:

Article

Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas.

Published in:

Prostate, 2019, v. 79, n. 3, p. 312, doi. 10.1002/pros.23737

By:

Yue, Limin;
Wang, Tao;
Ge, Yongchao;
Ge, Mengying;
Zhang, Chengda;
Hou, Quanliang;
Wang, Wenhua;
Tian, Huizi;
Ren, Bingnan;
Du, Binghui;
Zhang, Weidong

Publication type:

Article

Loss of CCAAT‐enhancer‐binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers.

Published in:

Prostate, 2019, v. 79, n. 3, p. 302, doi. 10.1002/pros.23736

By:

Minner, Sarah;
Lutz, Jannes;
Hube‐Magg, Claudia;
Kluth, Martina;
Simon, Ronald;
Höflmayer, Doris;
Burandt, Eike;
Tsourlakis, Maria Christina;
Sauter, Guido;
Büscheck, Franziska;
Wilczak, Waldemar;
Steurer, Stefan;
Schlomm, Thorsten;
Huland, Hartwig;
Graefen, Markus;
Haese, Alexander;
Heinzer, Hans;
Jacobsen, Frank;
Hinsch, Andrea;
Poos, Alexandra

Publication type:

Article

Death due to sepsis in patients diagnosed with prostate cancer.

Published in:

Prostate, 2019, v. 79, n. 3, p. 295, doi. 10.1002/pros.23735

By:

Alanee, Shaheen;
Holland, Bradley;
Clemons, Joseph;
Dynda, Danuta

Publication type:

Article

Urotensin II receptor expression in prostate cancer patients: A new possible marker.

Published in:

Prostate, 2019, v. 79, n. 3, p. 288, doi. 10.1002/pros.23734

By:

Giulianelli, Roberto;
Nardoni, Stefano;
Bruzzese, Dario;
Falavolti, Cristina;
Mirabile, Gabriella;
Bellangino, Mariangela;
Tema, Giorgia;
Gentile, Barbara Cristina;
Albanesi, Luca;
Buscarini, Maurizio;
Tariciotti, Paola;
Lombardo, Riccardo

Publication type:

Article

Clinical effectiveness of docetaxel for castration‐sensitive prostate cancer in a real‐world population‐based analysis.

Published in:

Prostate, 2019, v. 79, n. 3, p. 281, doi. 10.1002/pros.23733

By:

Lavoie, Jean‐Michel;
Zou, Kevin;
Khalaf, Daniel;
Eigl, Bernhard J.;
Kollmannsberger, Christian K.;
Vergidis, Joanna;
Noonan, Krista;
Zulfiqar, Muhammad;
Finch, Daygen;
Chi, Kim N.

Publication type:

Article

Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial).

Published in:

Prostate, 2019, v. 79, n. 3, p. 272, doi. 10.1002/pros.23732

By:

Meunier, Matthias E.;
Neuzillet, Yann;
Raynaud, Jean‐Pierre;
Radulescu, Camelia;
Ghoneim, Tarek;
Fiet, Jean;
Giton, Franck;
Rouanne, Mathieu;
Dreyfus, Jean‐François;
Lebret, Thierry;
Botto, Henry

Publication type:

Article

MicroRNAs as prognostic markers in prostate cancer.

Published in:

Prostate, 2019, v. 79, n. 3, p. 265, doi. 10.1002/pros.23731

By:

Suer, Ilknur;
Guzel, Esra;
Karatas, Omer F.;
Creighton, Chad J.;
Ittmann, Michael;
Ozen, Mustafa

Publication type:

Article

Tyrosine kinase inhibitor therapy prescribed for non‐urologic diseases can modify PSA titers in urology patients.

Published in:

Prostate, 2019, v. 79, n. 3, p. 259, doi. 10.1002/pros.23730

By:

Sasaki, Takeshi;
Franco, Omar E.;
Ohishi, Kohshi;
Filipovich, Yana;
Ishii, Kenichiro;
Crawford, Susan E.;
Takahashi, Naoto;
Katayama, Naoyuki;
Sugimura, Yoshiki;
Hayward, Simon W.

Publication type:

Article

Tumor cell heterogeneity and resistance; report from the 2018 Coffey‐Holden Prostate Cancer Academy Meeting.

Published in:

Prostate, 2019, v. 79, n. 3, p. 244, doi. 10.1002/pros.23729

By:

Miyahira, Andrea K.;
Den, Robert B.;
Carlo, Maria I.;
de Leeuw, Renée;
Hope, Thomas A.;
Karzai, Fatima;
McKay, Rana R.;
Salami, Simpa S.;
Simons, Jonathan W.;
Pienta, Kenneth J.;
Soule, Howard R.

Publication type:

Article

Issue Information.

Published in:: Prostate, 2019, v. 79, n. 3, p. 243, doi. 10.1002/pros.23670
Publication type:: Article